Skip to main content

Table 3 Total and incremental costs and effects

From: Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

  ST ERT Difference [95% confidence interval]
Life expectancy (years) 0.40 13.79 13.39 [1.55 – 25.23]
QALYs 0.24 7.00 6.75 [2.32 – 11.19]
Total costs € 32,871 € 7,032,899 € 7,000,028 [1,869,635 – 12,130,422]
- ERT costs € - € 6,630,525 € 6,630,525 [1,615,059 – 11,645,991]
- Infusion costs € - € 212,793 € 212,793 [121,477 – 304,108]
- Other costs € 32,871 € 189,582 € 156,711 [131,728 – 181,694]
  1. ST supportive therapy, ERT enzyme replacement therapy, QALY quality adjusted life year.